Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. [No authors listed] DR Gandara, SM Paul, M Kowanetz, E Schleifman… - Nature medicine, 2018 - nature.com GSID: 2V8Yzzb_VMUJ
Integrated digital error suppression for improved detection of circulating tumor DNA. Klass DM, Kurtz DM, Newman AM. AM Newman, AF Lovejoy, DM Klass, DM Kurtz… - Nature …, 2016 - nature.com GSID: kgqoDHy6secJ
Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non–small cell lung cancer. [No authors listed] GSID: Uh_gVrjJMTsJ
